Document is current
Any future updates will be listed below
-
Authors
Ma, Zeliang
Liu, Yunsong
Bao, Yongxing
Liu, Qian
Yang, Xu
Men, Yu
Wang, Jianyang
Deng, Lei
Zhai, Yirui
Hu, Chen
Bi, Nan
Wang, Luhua
Hui, Zhouguang
-
Funding
Funding for this research was provided by:
National key research and development program (2022YFC2705001)
Capital’s Funds for Health Improvement and Research (2022-1-4022)
Beijing Xisike Clinical Oncology Research Foundation (Y-HR2020ZD-0779)
Beijing Hope Run Special Fund of Cancer Foundation of China (ZZ2021A02)
- License Information
-
More Information
Article History
Received: 13 November 2023
Accepted: 25 July 2024
First Online: 8 August 2024
Declarations
:
: The study was approved by the Ethics Committee of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (No. 22/292–3494). Written informed consent was waived for the use of anonymized retrospective data. The principles of the Declaration of Helsinki were followed.
: The authors declare no competing interests.
